MicroRNAs and drug modulation in cancer: An intertwined new story

Research output: Contribution to journalArticle

Abstract

MicroRNAs (miRNAs) are endogenous small non-coding RNAs (ncRNAs) which play important regulatory roles in physiological processes such as cellular differentiation, proliferation, development, apoptosis and stem cell self-renewal. An increasing number of papers have clearly claimed their involvement in cancer, providing, in some cases, also the molecular mechanisms implicated. Several studies led to the conclusion that miRNAs can be effectively used as anticancer agents alone or in combination with existing anticancer drugs. In particular, miRNAs can be effectively used to overcome drug resistance, one of the main factors responsible for anticancer treatment insuccess. One of the main questions remains how to modulate the expression of miRNAs in cancer cells. Interestingly, a few studies have shown that the expression of miRNAs is affected by drugs (including some drugs currently used as anticancer agents), therefore providing the rationale for an intertwined scenario in which miRNAs can be modulated by drugs and, in turn, can affect drug sensitivity of cancer cells.

Original languageEnglish
Pages (from-to)351-356
Number of pages6
JournalFrontiers in Biology
Volume6
Issue number5
DOIs
Publication statusPublished - Oct 2011

Fingerprint

MicroRNAs
microRNA
cancer
drug
drugs
neoplasms
antineoplastic agents
Pharmaceutical Preparations
Neoplasms
Antineoplastic Agents
drug resistance
Physiological Phenomena
apoptosis
Small Untranslated RNA
RNA
Drug Resistance
stem cells
Cell Proliferation
Apoptosis

Keywords

  • cancer
  • chemotherapy
  • miRNAs
  • multidrug resistance
  • transcription factor

ASJC Scopus subject areas

  • Ecology, Evolution, Behavior and Systematics
  • Biotechnology
  • Genetics
  • Ecology

Cite this

MicroRNAs and drug modulation in cancer : An intertwined new story. / Fanini, Francesca; Vannini, Ivan; Fabbri, Muller.

In: Frontiers in Biology, Vol. 6, No. 5, 10.2011, p. 351-356.

Research output: Contribution to journalArticle

@article{79d3a1e2421f4589bdc9c2919bd8b66d,
title = "MicroRNAs and drug modulation in cancer: An intertwined new story",
abstract = "MicroRNAs (miRNAs) are endogenous small non-coding RNAs (ncRNAs) which play important regulatory roles in physiological processes such as cellular differentiation, proliferation, development, apoptosis and stem cell self-renewal. An increasing number of papers have clearly claimed their involvement in cancer, providing, in some cases, also the molecular mechanisms implicated. Several studies led to the conclusion that miRNAs can be effectively used as anticancer agents alone or in combination with existing anticancer drugs. In particular, miRNAs can be effectively used to overcome drug resistance, one of the main factors responsible for anticancer treatment insuccess. One of the main questions remains how to modulate the expression of miRNAs in cancer cells. Interestingly, a few studies have shown that the expression of miRNAs is affected by drugs (including some drugs currently used as anticancer agents), therefore providing the rationale for an intertwined scenario in which miRNAs can be modulated by drugs and, in turn, can affect drug sensitivity of cancer cells.",
keywords = "cancer, chemotherapy, miRNAs, multidrug resistance, transcription factor",
author = "Francesca Fanini and Ivan Vannini and Muller Fabbri",
year = "2011",
month = "10",
doi = "10.1007/s11515-011-1115-9",
language = "English",
volume = "6",
pages = "351--356",
journal = "Frontiers in Biology",
issn = "1674-7984",
publisher = "Higher Education Press",
number = "5",

}

TY - JOUR

T1 - MicroRNAs and drug modulation in cancer

T2 - An intertwined new story

AU - Fanini, Francesca

AU - Vannini, Ivan

AU - Fabbri, Muller

PY - 2011/10

Y1 - 2011/10

N2 - MicroRNAs (miRNAs) are endogenous small non-coding RNAs (ncRNAs) which play important regulatory roles in physiological processes such as cellular differentiation, proliferation, development, apoptosis and stem cell self-renewal. An increasing number of papers have clearly claimed their involvement in cancer, providing, in some cases, also the molecular mechanisms implicated. Several studies led to the conclusion that miRNAs can be effectively used as anticancer agents alone or in combination with existing anticancer drugs. In particular, miRNAs can be effectively used to overcome drug resistance, one of the main factors responsible for anticancer treatment insuccess. One of the main questions remains how to modulate the expression of miRNAs in cancer cells. Interestingly, a few studies have shown that the expression of miRNAs is affected by drugs (including some drugs currently used as anticancer agents), therefore providing the rationale for an intertwined scenario in which miRNAs can be modulated by drugs and, in turn, can affect drug sensitivity of cancer cells.

AB - MicroRNAs (miRNAs) are endogenous small non-coding RNAs (ncRNAs) which play important regulatory roles in physiological processes such as cellular differentiation, proliferation, development, apoptosis and stem cell self-renewal. An increasing number of papers have clearly claimed their involvement in cancer, providing, in some cases, also the molecular mechanisms implicated. Several studies led to the conclusion that miRNAs can be effectively used as anticancer agents alone or in combination with existing anticancer drugs. In particular, miRNAs can be effectively used to overcome drug resistance, one of the main factors responsible for anticancer treatment insuccess. One of the main questions remains how to modulate the expression of miRNAs in cancer cells. Interestingly, a few studies have shown that the expression of miRNAs is affected by drugs (including some drugs currently used as anticancer agents), therefore providing the rationale for an intertwined scenario in which miRNAs can be modulated by drugs and, in turn, can affect drug sensitivity of cancer cells.

KW - cancer

KW - chemotherapy

KW - miRNAs

KW - multidrug resistance

KW - transcription factor

UR - http://www.scopus.com/inward/record.url?scp=80053643008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053643008&partnerID=8YFLogxK

U2 - 10.1007/s11515-011-1115-9

DO - 10.1007/s11515-011-1115-9

M3 - Article

AN - SCOPUS:80053643008

VL - 6

SP - 351

EP - 356

JO - Frontiers in Biology

JF - Frontiers in Biology

SN - 1674-7984

IS - 5

ER -